Improving access to SLE therapies in low and middle-income countries

Claudia Mendoza-Pinto, Ivet Etchegaray-Morales, Manuel F. Ugarte-Gil

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


SLE increases disease burden in those affected with it, and that is particularly the case in low- and middle-income countries. The 2019 Addressing Lupus Pillar of Health Advancement project is a multiphase initiative whose objective is to recognize, hierarchize and establish approaches for diligent SLE research, care and access to healthcare. Lack of access to high-cost medications that have been shown to be efficacious in the short term and that potentially reduce damage in SLE is a complex issue. In this review, we highlight opportunities and plans of action to diminish costs and improve access to therapies, which should be recognized and executed, preferably within regional strategies with multiple stakeholders (including supranational organizations, governments, the pharmaceutical industry, medical societies and the general population) connected with and grounded in structured and clear cost-effectiveness analysis.

Original languageEnglish
Pages (from-to)I30-I35
JournalRheumatology (United Kingdom)
StatePublished - 1 Apr 2023


  • SLE
  • access to healthcare
  • low- and middle-income countries


Dive into the research topics of 'Improving access to SLE therapies in low and middle-income countries'. Together they form a unique fingerprint.

Cite this